Furthermore, Fonja et al. found that anti-estrogen and Herceptin induced the expression of PDCD4, revealing that the intracellular crosstalk of RAR, ER, and Her-2 may play a role in growth inhibitory signalling in breast cancer cells [43]. Here, ERBB2 is linked to breast cancer.